Date | Time | Source | Announcement |
---|---|---|---|
19 Dec 2008 | 12:56 PM | Issue of Equity | |
20 Nov 2008 | 07:00 AM | Notice of Results | |
24 Sep 2008 | 07:01 AM | Audited Final Results for the Year Ended 30 Apr... | |
24 Sep 2008 | 07:00 AM | Admission and Start of Trading |
Scancell Holdings PLC is a biopharmaceutical company that develops vaccines and other therapies to treat cancer and infectious diseases. Scancell's research focuses on the human immune system and how to use it to develop new treatments. Scancell uses four technology platforms to develop its products: ImmunoBody, Moditope, GlyMab and AvidiMab.
Scancell was founded in 1997 based on research led by Professor Lindy Durrant at the University of Nottingham.
Scancell Holdings PLC is listed on the London Stock Exchange (LSE) as SCLP.
Scancell share price listed at 8p in 2010.